Sunday, August 19, 2018 10:44:46 PM
I don't think that LP threw longs under the bus as you call it. The decimation of the share price was caused by lack of reported results. This was all FUDDED by investors going the other way and perhaps illegally. Right now, we have no smoking gun proof. LP and company decided that silence was the best policy. I don't think saying anything short of great results would have saved the pps. The length of the trial and the uncertainty it has bred has been a major cause of the decimation. Obviously, vultures took advantage of all this and drove the pps lower. But LP has put her money where her belief is. Sure she has monetised Cognate and maybe, to some extent, it was on longs' backs, but LP is not stupid and is not going to waste good money after bad if she does not believe that the odds are in favour of success. She has a lot more info and experts versus the general investor and has skin in the game. These small biotechs are risky. Attacks are common with investors going the other way. And there are good arguments for it. I am betting in favour of success. IMHO, I think that argument is better. LP's willingness to put money in regardless of how she may have raised it has got to be a positive. Yes, she has a better deal than most retail, but she stepped up to the plate, so I don't really blame her for getting a better deal. If she succeeds, so do longs. We may not get the $100, $50 or even $20 we had hoped for but at my base investment, and I averaged down considerably, I would be happy with $3 which is reasonable if DC VAX L is even somewhat successful. I don't like where the pps are and I am as frustrated as the next investor. The pub is certainly very encouraging and so is the support from a number of physicians/scientists. I think that the pps are severely undervalued. Shorts and bashers don't. Differences of opinions are what make a horse race. I believe that DC VAX L will receive approval and it will be broad as it appears to work across all groups to a greater or lesser extent. Each tumour(s) is different and personalised. That is what DC VAX L is all about. JMHO.
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM